Overview

Lorcaserin for Preventing Weight Gain Among Smokers

Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
This will be an open label clinical trial with all subjects receiving both lorcaserin and varenicline with a primary aim of reducing post cessation weight gain.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Mayo Clinic
Treatments:
Varenicline